The Connecticut resident said she’s a woman of strong faith who believes in the power of prayer and that’s all that helped to ...

The key secondary end point of overall survival (OS) was met in the DREAMM-7 trial of belantamab mafodotin (Blenrep; GSK) for the treatment of patients with relapsed/refractory multiple myeloma (R/R ...

Researchers sought to better understand the experiences of patients living with multiple myeloma and their perceptions of palliative care.

This important study identifies the "H-state" as a potential conformational marker distinguishing amyloidogenic from non-amyloidogenic light chains, addressing a critical problem in protein misfolding ...

Johnson & Johnson announced today more than 90 abstracts featuring data from the Company's differentiated blood cancer portfolio and pipeline will be presented at the 66th American Society of ...

Telo Genomics holds an IP patent portfolio of 23 patents and pending patent applications in Canada, US and Europe. The portfolio includes patents that govern its core 3D telomere technology TeloView, ...

“At the moment, it's taking four or five weeks to see an oncologist for a patient who's suspected of having cancer,” said ...

Johnson & Johnson faces uncertainty with speculation about RFK Jr. at HHS. Learn why JNJ stock remains a buy despite ...

Shares of Legend Biotech Co. (NASDAQ:LEGN – Get Free Report) have earned an average recommendation of “Buy” from the thirteen ...

Geraldine Ferraro is remembered as a pioneering figure in American politics, a woman who broke barriers and challenged the ...